PDS Biotechnology Corp Files Form 8-K with US SEC
Summary
PDS Biotechnology Corp has filed a Form 8-K disclosing a material definitive agreement and direct financial obligation.
Prepared by the newsroom with AI assistance; the original link is always provided
PDS Biotechnology Corp has submitted a Form 8-K filing to the U.S. Securities and Exchange Commission (SEC).
According to the regulatory report, the company entered into a material definitive agreement under Item 1.01 and established a direct financial obligation under Item 2.03. The filing also contains financial statements and related exhibits under Item 9.01.
Source: SEC EDGAR
Read the original →Latest news
Bank CenterCredit Repurchases Shares for 18.2B Tenge on KASE
Bank CenterCredit JSC has repurchased 4.1 million of its common shares on the Kazakhstan Stock Exchange for 18.2 billion tenge.
Source: KASE
Home Credit Bank Bonds Added to KASE T+ List
Starting October 8, Home Credit Bank bonds (KZQ000001213, HCBNe1) will be included in the KASE T+ List.
Source: KASE
KASE Publishes Member Activity Rankings for September 2026
Kazakhstan Stock Exchange has released its exchange member activity rankings for September 2026 on its official website.
Source: KASE
KASE Index rises 0.25% to 7,862.81 points
On October 7, the KASE Index climbed by 0.25% to settle at 7,862.81 points.
Source: KASE